References
Awini, E.A., Bonney, J.H.K., Frimpong, J.A., Ampofo, W.K., Koram, K.A., 2017. Information gaps in surveillance data and effects on the Ghanaian response to the Ebola outbreak in West Africa. Ghana medical journal 51, 115-119.
Baize, S., Pannetier, D., Oestereich, L., Rieger, T., Koivogui, L., Magassouba, N., Soropogui, B., Sow, M.S., Keita, S., De Clerck, H., Tiffany, A., Dominguez, G., Loua, M., Traore, A., Kolie, M., Malano, E.R., Heleze, E., Bocquin, A., Mely, S., Raoul, H., Caro, V., Cadar, D., Gabriel, M., Pahlmann, M., Tappe, D., Schmidt-Chanasit, J., Impouma, B., Diallo, A.K., Formenty, P., Van Herp, M., Gunther, S., 2014. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 371, 1418-1425.
Cantoni, D., Rossman, J.S., 2018. Ebolaviruses: New roles for old proteins. PLoS Negl Trop Dis 12, e0006349.
Chen, Q., Tang, K., Zhang, X., Chen, P., Guo, Y., 2018. Establishment of pseudovirus infection mouse models for in vivo pharmacodynamics evaluation of filovirus entry inhibitors. Acta pharmaceutica Sinica. B 8, 200-208.
Cheresiz, S.V., Kononova, A.A., Razumova, Y.V., Dubich, T.S., Chepurnov, A.A., Kushch, A.A., Davey, R., Pokrovsky, A.G., 2014. A vesicular stomatitis pseudovirus expressing the surface glycoproteins of influenza A virus. Archives of Virology 159, 2651-2658.
Gire, S.K., Goba, A., Andersen, K.G., Sealfon, R.S., Park, D.J., Kanneh, L., Jalloh, S., Momoh, M., Fullah, M., Dudas, G., Wohl, S., Moses, L.M., Yozwiak, N.L., Winnicki, S., Matranga, C.B., Malboeuf, C.M., Qu, J., Gladden, A.D., Schaffner, S.F., Yang, X., Jiang, P.P., Nekoui, M., Colubri, A., Coomber, M.R., Fonnie, M., Moigboi, A., Gbakie, M., Kamara, F.K., Tucker, V., Konuwa, E., Saffa, S., Sellu, J., Jalloh, A.A., Kovoma, A., Koninga, J., Mustapha, I., Kargbo, K., Foday, M., Yillah, M., Kanneh, F., Robert, W., Massally, J.L., Chapman, S.B., Bochicchio, J., Murphy, C., Nusbaum, C., Young, S., Birren, B.W., Grant, D.S., Scheiffelin, J.S., Lander, E.S., Happi, C., Gevao, S.M., Gnirke, A., Rambaut, A., Garry, R.F., Khan, S.H., Sabeti, P.C., 2014. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 345, 1369-1372.
Harrod, K.S., 2015. Ebola: history, treatment, and lessons from a new emerging pathogen. Am J Physiol Lung Cell Mol Physiol 308, L307-313.
Konduru, K., Shurtleff, A.C., Bavari, S., Kaplan, G., 2018. High degree of correlation between Ebola virus BSL-4 neutralization assays and pseudotyped VSV BSL-2 fluorescence reduction neutralization test. J Virol Methods 254, 1-7.
Lee, J.E., Fusco, M.L., Hessell, A.J., Oswald, W.B., Burton, D.R., Saphire, E.O., 2008. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454, 177-182.
Lee, S.S., Phy, K., Peden, K., Sheng-Fowler, L., 2017. Development of a micro-neutralization assay for ebolaviruses using a replication-competent vesicular stomatitis hybrid virus and a quantitative PCR readout. Vaccine 35, 5481-5486.
Lennemann, N.J., Herbert, A.S., Brouillette, R., Rhein, B., Bakken, R.A., Perschbacher, K.J., Cooney, A.L., Miller-Hunt, C.L., Ten Eyck, P., Biggins, J., Olinger, G., Dye, J.M., Maury, W., 2017. Vesicular Stomatitis Virus Pseudotyped with Ebola Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against Ebola Virus Challenge in Mice. Journal of Virology 91.
Maruyama, T., Rodriguez, L.L., Jahrling, P.B., Sanchez, A., Khan, A.S., Nichol, S.T., Peters, C.J., Parren, P.W., Burton, D.R., 1999. Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol 73, 6024-6030.
Mbala Kingebeni, P., Villabona-Arenas, C.J., Vidal, N., Likofata, J., Nsio-Mbeta, J., Makiala-Mandanda, S., Mukadi, D., Mukadi, P., Kumakamba, C., Djokolo, B., Ayouba, A., Delaporte, E., Peeters, M., Muyembe Tamfum, J.J., Ahuka Mundeke, S., 2018. Rapid confirmation of the Zaire Ebola Virus in the outbreak of the Equateur province in the Democratic Republic of Congo: implications for public health interventions. Clin Infect Dis.
Mohan, G.S., Li, W., Ye, L., Compans, R.W., Yang, C., 2012. Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus. PLoS Pathog 8, e1003065.
Nkengasong, J.N., Onyebujoh, P., 2018. Response to the Ebola virus disease outbreak in the Democratic Republic of the Congo. Lancet 391, 2395-2398.
Panina, A.A., Dementieva, I.G., Aliev, T.K., Toporova, V.A., Balabashin, D.S., Bokov, M.N., Pozdnyakova, L.P., Shchemchukova, O.B., Dolgikh, D.A., Sveshnikov, P.G., Kirpichnikov, M.P., 2017. Recombinant Antibodies to the Ebola Virus Glycoprotein. Acta Naturae 9, 84-91.
Qiu, C., Huang, Y., Zhang, A., Tian, D., Wan, Y., Zhang, X., Zhang, W., Zhang, Z., Yuan, Z., Hu, Y., 2013. Safe Pseudovirus-based Assay for Neutralization Antibodies against Influenza A(H7N9) Virus. Emerging Infectious Diseases 19, 1685-1687.
Qiu, X., Wong, G., Audet, J., Bello, A., Fernando, L., Alimonti, J.B., Fausther-Bovendo, H., Wei, H., Aviles, J., Hiatt, E., Johnson, A., Morton, J., Swope, K., Bohorov, O., Bohorova, N., Goodman, C., Kim, D., Pauly, M.H., Velasco, J., Pettitt, J., Olinger, G.G., Whaley, K., Xu, B., Strong, J.E., Zeitlin, L., Kobinger, G.P., 2014. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514, 47-53.
Shrivastava-Ranjan, P., Flint, M., Bergeron, E., McElroy, A.K., Chatterjee, P., Albarino, C.G., Nichol, S.T., Spiropoulou, C.F., 2018. Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing. mBio 9.
Subissi, L., Keita, M., Mesfin, S., Rezza, G., Diallo, B., Van Gucht, S., Musa, E.O., Yoti, Z., Keita, S., Djingarey, M.H., Diallo, A.B., Fall, I.S., 2018. Ebola Virus Transmission Caused by Persistently Infected Survivors of the 2014-2016 Outbreak in West Africa. J Infect Dis.
Sullivan, N.J., Hensley, L., Asiedu, C., Geisbert, T.W., Stanley, D., Johnson, J., Honko, A., Olinger, G., Bailey, M., Geisbert, J.B., Reimann, K.A., Bao, S., Rao, S., Roederer, M., Jahrling, P.B., Koup, R.A., Nabel, G.J., 2011. CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates. Nat Med 17, 1128-1131.
Tong, Y.G., Shi, W.F., Liu, D., Qian, J., Liang, L., Bo, X.C., Liu, J., Ren, H.G., Fan, H., Ni, M., Sun, Y., Jin, Y., Teng, Y., Li, Z., Kargbo, D., Dafae, F., Kanu, A., Chen, C.C., Lan, Z.H., Jiang, H., Luo, Y., Lu, H.J., Zhang, X.G., Yang, F., Hu, Y., Cao, Y.X., Deng, Y.Q., Su, H.X., Sun, Y., Liu, W.S., Wang, Z., Wang, C.Y., Bu, Z.Y., Guo, Z.D., Zhang, L.B., Nie, W.M., Bai, C.Q., Sun, C.H., An, X.P., Xu, P.S., Zhang, X.L., Huang, Y., Mi, Z.Q., Yu, D., Yao, H.W., Feng, Y., Xia, Z.P., Zheng, X.X., Yang, S.T., Lu, B., Jiang, J.F., Kargbo, B., He, F.C., Gao, G.F., Cao, W.C., China Mobile Laboratory Testing Team in Sierra, L., 2015. Genetic diversity and evolutionary dynamics of Ebola virus in Sierra Leone. Nature 524, 93-96.
Volchkov, V.E., Volchkova, V.A., Slenczka, W., Klenk, H.D., Feldmann, H., 1998. Release of viral glycoproteins during Ebola virus infection. Virology 245, 110-119.
Yu, D.S., Weng, T.H., Wu, X.X., Wang, F.X.C., Lu, X.Y., Wu, H.B., Wu, N.P., Li, L.J., Yao, H.P., 2017. The lifecycle of the Ebola virus in host cells. Oncotarget 8, 55750-55759.
Zhao, G.Y., Du, L.Y., Ma, C.Q., Li, Y., Li, L., Poon, V.K.M., Wang, L.L., Yu, F., Zheng, B.J., Jiang, S.B., Zhou, Y.S., 2013. A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV. Virology Journal 10.
Zheng, X., Wong, G., Zhao, Y., Wang, H., He, S., Bi, Y., Chen, W., Jin, H., Gai, W., Chu, D., Cao, Z., Wang, C., Fan, Q., Chi, H., Gao, Y., Wang, T., Feng, N., Yan, F., Huang, G., Zheng, Y., Li, N., Li, Y., Qian, J., Zou, Y., Kobinger, G., Gao, G.F., Qiu, X., Yang, S., Xia, X., 2016. Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection. Sci Rep 6, 24179.